| Centre hospitalier universitaire de Rennes | |
| Coordinates: | 48.1208°N -1.6964°W |
| Country: | France |
| Type: | Teaching, CHU |
| Emergency: | Yes |
| Location: | Rennes, Brittany |
The Rennes University Hospital (French: link=no|Centre hospitalier universitaire de Rennes or CHU Rennes) is a university hospital in Rennes in France. It employs 7,700 people[1] and processes nearly 1,500 hospitalisations per day. It was the second largest employer in the Rennes region.[2] It is one of 42 French hospital equipped with the da Vinci Surgical System.
In 2014, the Rennes University Hospital was ranked in the top 10 hospitals in France.[3]
Research at CHU Rennes has included a study of the efficacy of nalmefene.[4] [5]
In 2016, a facility run by the private contract research organization Biotrial, running clinical trials required patients to be admitted to CHU Rennes.[6] The facility ran a phase one study into a new drug being developed by Bial that targets the human endocannabinoid system.[7] The study failed catastrophically, leaving six subjects hospitalized and one brain dead.[8] [9]